Pharmacotherapeutic Management of Cardiovascular Disease Complications: A Textbook for Medical Students

Role of Biomarkers in Detection of Cardiovascular Diseases

Author(s): A. Bharath Kumar and M.S. Umashankar

Pp: 13-24 (12)

DOI: 10.2174/9789811468216120010003

* (Excluding Mailing and Handling)


Cardiovascular diseases cause more deaths in the world. Atherosclerotic plaques cause thrombus formation in the blood vessels leads to impediment in the vascular lumen can create a complete blockage of the blood vessels which increases the risk of developing coronary artery disease. The biomarker is used to assess the biological process and pharmacological responses of the drugs to a targeted intervention. It is used to identify the disease progression burden among the affected population. The cardiovascular biomarkers include B-type natriuretic peptide, urinary NGAL, troponin, C-reactive protein, N-terminal prohormone BNP, myeloperoxidase, lipoprotein-associated phospholipase A2, cytokine IL-37, troponin, fibrinogen, metalloproteinase-1, and cystatin C is used to predict the risk of progression of cardiovascular diseases.

Keywords: Biomarker, Cardiovascular Disease, Coronary Artery Disease, Risk Prediction, Therapeutic Interventions.

Related Journals
Related Books
© 2024 Bentham Science Publishers | Privacy Policy